EP3226887
ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.12.2015EP published:
27.3.2024EP application number:
15865103.4
EPO information:
European Patent Register
Max expiry date:
2.12.2035
Title in English:
ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIALanguage of the patent:
English
Timeline
Today
3.12.2015EP application
27.3.2024EP Publication
Owner
Name:
Acceleron Pharma Inc.Address:
128 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
ATTIE, Kenneth, M.Address:
Boston, MA 02116, US
Name:
ROVALDI, Christopher, RobertAddress:
Swampscott, MA 01907, US
Priority
Number:
201462086977 PDate:
3.12.2014Country:
US
Number:
201462088087 PDate:
5.12.2014Country:
US
Number:
201562155395 PDate:
30.4.2015Country:
US
Classification
Categories:
A61K 35/18, A61K 38/18, A61K 35/14, A61K 38/17, A61K 39/395, C07K 14/495, C07K 14/71, C12Q 1/6883, A61P 7/00, A61P 7/06, A61P 35/02, A61P 43/00